​

Core Laboratories (CLB) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CLB Stock Forecast

Core Laboratories (CLB) stock forecast, based on 31 Wall Street analysts, predicts a 12-month average price target of $25.00, with a high of $32.00 and a low of $17.00. This represents a 98.10% increase from the last price of $12.62.

$10 $15 $20 $25 $30 $35 High: $32 Avg: $25 Low: $17 Last Closed Price: $12.62

CLB Stock Rating

Core Laboratories stock's rating consensus is Buy, based on 31 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (48.39%), 13 Hold (41.94%), 3 Sell (9.68%), and 0 Strong Sell (0.00%).

Buy
Total 31 0 3 13 15 Strong Sell Sell Hold Buy Strong Buy

CLB Price Target Upside V Benchmarks

TypeNameUpside
StockCore Laboratories98.10%
SectorEnergy Stocks 38.68%
IndustryOil & Gas Equipment & Services Stocks43.76%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$17.00
Last Closing Price$12.62$12.62$12.62
Upside/Downside--34.71%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 251-4-16
Mar, 251-3116
Feb, 251-3116
Jan, 251-3116
Dec, 241-4117
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 15, 2024Luke LemoinePiper Sandler$17.00$21.78-21.95%34.71%
Feb 07, 2023Citigroup$26.00$26.21-0.80%106.02%
May 02, 2022Morgan Stanley$32.00$26.6520.08%153.57%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 12, 2025CitigroupNeutralNeutralupgrade
Jul 15, 2024Piper SandlerNeutralNeutralhold
Feb 07, 2023CitigroupNeutralNeutralhold
Jan 09, 2023Bank of America SecuritiesNeutralupgrade
Oct 06, 2022CitigroupNeutralupgrade
Sep 26, 2022Morgan StanleyEqual-WeightUnderweightdowngrade
May 02, 2022Morgan StanleyEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.18$0.51$0.42$0.79$0.66----
Avg Forecast$0.74$0.67$0.53$0.81$0.88$0.97$1.15$1.34$1.48
High Forecast$0.75$0.68$0.54$0.82$0.89$0.99$1.18$1.38$1.52
Low Forecast$0.73$0.66$0.52$0.79$0.87$0.95$1.12$1.31$1.45
Surprise %-394.59%-23.88%-20.75%-2.47%-25.00%----

Revenue Forecast

$450M $490M $530M $570M $610M $650M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$487.27M$470.25M$489.74M$509.79M$523.85M----
Avg Forecast$482.78M$474.19M$491.94M$509.39M$526.79M$543.48M$559.00M$599.00M$623.00M
High Forecast$490.52M$481.79M$499.38M$510.86M$538.72M$543.53M$571.01M$601.50M$637.11M
Low Forecast$476.37M$467.89M$485.36M$507.86M$526.78M$543.43M$547.00M$596.50M$611.97M
Surprise %0.93%-0.83%-0.45%0.08%-0.56%----

Net Income Forecast

$-150M $-100M $-50M $0 $50M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-97.07M$19.73M$19.45M$36.67M$31.40M----
Avg Forecast$-107.15M$18.95M$9.95M$36.67M$42.01M$47.12M$54.79M$64.10M$70.57M
High Forecast$-79.88M$22.74M$12.77M$47.10M$42.49M$47.36M$56.22M$65.78M$72.65M
Low Forecast$-134.42M$15.16M$7.12M$26.25M$41.53M$45.53M$53.36M$62.43M$68.95M
Surprise %-9.40%4.10%95.58%--25.26%----

CLB Forecast FAQ

Is Core Laboratories stock a buy?

Core Laboratories stock has a consensus rating of Buy, based on 31 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 13 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Core Laboratories is a favorable investment for most analysts.

What is Core Laboratories's price target?

Core Laboratories's price target, set by 31 Wall Street analysts, averages $25 over the next 12 months. The price target range spans from $17 at the low end to $32 at the high end, suggesting a potential 98.10% change from the previous closing price of $12.62.

How does Core Laboratories stock forecast compare to its benchmarks?

Core Laboratories's stock forecast shows a 98.10% upside, outperforming the average forecast for the energy stocks sector (38.68%) and outperforming the oil & gas equipment & services stocks industry (43.76%).

What is the breakdown of analyst ratings for Core Laboratories over the past three months?

  • April 2025: 16.67% Strong Buy, 0% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.
  • March 2025: 16.67% Strong Buy, 0% Buy, 50.00% Hold, 16.67% Sell, 16.67% Strong Sell.
  • February 2025: 16.67% Strong Buy, 0% Buy, 50.00% Hold, 16.67% Sell, 16.67% Strong Sell.

What is Core Laboratories’s EPS forecast?

Core Laboratories's average annual EPS forecast for its fiscal year ending in December 2025 is $0.97, marking a 46.97% increase from the reported $0.66 in 2024. Estimates for the following years are $1.15 in 2026, $1.34 in 2027, and $1.48 in 2028.

What is Core Laboratories’s revenue forecast?

Core Laboratories's average annual revenue forecast for its fiscal year ending in December 2025 is $543.48M, reflecting a 3.75% increase from the reported $523.85M in 2024. The forecast for 2026 is $559M, followed by $599M for 2027, and $623M for 2028.

What is Core Laboratories’s net income forecast?

Core Laboratories's net income forecast for the fiscal year ending in December 2025 stands at $47.12M, representing an 50.06% increase from the reported $31.4M in 2024. Projections indicate $54.79M in 2026, $64.1M in 2027, and $70.57M in 2028.